Skip to main content
. 2022 Nov 18;37(4):2659–2672. doi: 10.1007/s00464-022-09735-4

Table 3.

Patient- and surgical outcomes on all minimally invasive pancreatic resections

Characteristics Laparoscopic pancreatoduodenectomy
N = 52
Robotic pancreatoduodenectomy N = 111 P Laparoscopic distal pancreatectomy
N = 123
Operation time, minutes, median [IQR] 450 [411–518] 361 [330–406]  < 0.001 251 [206–322]
Blood loss, ml, median [IQR] 350 [250–500] 200 [100–350]  < 0.001 200 [50–350]
Drain placement 52 (100) 111 (100) 0.581 108 (87.8)
Pancreatic texture, soft, n (%) 35 (67.3) 70 (63.1) 0.869 65 (52.8)
Duct size in mm, median [IQR] 3 [2–4] 3 [2–5] 0.475 1 [1–2]
Vascular resection n (%) 2 (3.8) 3 (2.7) 0.693 1 (0.8)
Multi-visceral resection, n (%) 1 (1.9) 0.143 23 (18.7)
Conversion, n (%) 4 (7.7) 3 (2.7) 0.143 8 (6.5)
Complications
Postoperative pancreatic fistula grade B/C 17 (32.7) 50 (45.0) 0.135 44 (35.8)
Post-pancreatectomy hemorrhage grade B/C, n (%) 7 (13.5) 8 (7.2) 0.198 6 (4.9)
Delayed gastric emptying grade B/C, n (%) 15 (28.8) 11 (9.9) 0.009 6 (4.9)
Bile leakage grade B/C, n (%) 7 (13.4) 10 (9.0) 0.386 -
Clavien Dindo > 3a, n (%) 22 (42.3) 62 (55.9) 0.085 36 (29.3)
Length of stay, days, median [IQR] 12 [719] 10 [721] 0.463 5 [47]
R0 resection in case of malignancy, n (%) 36 (94.7) 62 (84.9) 0.127 39 (69.6)
Reoperation, n (%) 4 (7.7) 14 (12.6) 0.350 2 (1.6)
Readmission, n (%) 6 (11.5) 26 (23.4) 0.075 31 (25.2)
In-hospital/30-day mortality, n (%) 2 (3.8) 3 (2.7) 0.693 2 (1.6)
Adjuvant therapy in patients with cancer, n (%) 11 (27.5) 23 (20.7) 0.949 19 (15.4)

Bold values indicate statistical significance (p < 0.05)

Values in parentheses are percentages unless mentioned otherwise

IQR inter quartile range